Viewing StudyNCT01185366



Ignite Creation Date: 2024-05-05 @ 10:46 PM
Last Modification Date: 2024-10-26 @ 10:24 AM
Study NCT ID: NCT01185366
Status: TERMINATED
Last Update Posted: 2021-04-28
First Post: 2010-08-18

Brief Title: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: 2009-0628
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Novartis INDUSTRY